do glp 1 drugs cause blindness Does GLP-1 Eye Problems? Retinopathy Risks Explained iLIV Clinic | 👀 You've

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

The PatchAid Berberine Patch delivers a plant-based formula straight through your skin

Learn what GLP-1 agonists and antagonists are and how they work

No direct causal link has been established between GLP-1R use and increased aspiration risk

Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.